Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 23, 2002
Aspects of haemophilia prophylaxis in SwedenR C R LjungHaemophilia : the Official Journal of the World Federation of Hemophilia|July 2, 2010
The role of prophylaxis in bleeding disordersE Berntorp, P de Moerloose, R C R LjungHaemophilia : the Official Journal of the World Federation of Hemophilia|May 8, 2008
Why does the mutation G17736A/Val107Val (silent) in the F9 gene cause mild haemophilia B in five Swedish families?K E Knobe, E Sjörin, R C R LjungHaemophilia : the Official Journal of the World Federation of Hemophilia|August 30, 2002
Breastfeeding does not influence the development of inhibitors in haemophiliaK E Knobe, L I Tengborn, P Petrini, et al.Acta Paediatrica (Oslo, Norway : 1992)|September 12, 2002
Inhibitors in the Swedish population with severe haemophilia A and B: a 20-year surveyK E Knobe, E Sjörin, L I Tengborn, et al.Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Functional analysis of the EGF-like domain mutations Pro55Ser and Pro55Leu, which cause mild hemophilia BK E Knobe, K E M Persson, E Sjörin, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2010
The need for speed in the management of haemophilia patients with inhibitorsS Z Salek, G M Benson, I Elezović, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|February 20, 2008
Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitorsW K Hoots, L S Ebbesen, B A Konkle, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|August 29, 2009
Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needsE Santagostino, M Morfini, G K-H Auerswald, et al.Pageof 1